Ublituximab’s Therapeutic Benefit Revealed & Giving MS Medications Another Try

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how TG Therapeutics presented additional Phase 3 trial data indicating that ublituximab improves disability and quality of life in people with MS.

He also reads “Why I’m Giving 3 MS Medications Another Try” from Ed Tobias’ column, “The MS Wire.”

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/